As Ebola fears again spread beyond Africa, the world faces a familiar question: How best to react to the threat? What lessons from past... Read More
Next week, a House Judiciary subcommittee will revisit familiar accusations about pharmaceutical patents and drug prices. Testimony will... Read More
Vance’s task force can find the fraud. The question is whether it can make the state see what it was designed not to. Read More
More observations from the history of a very bad idea. Read More
For the first time, the U.S. government acknowledges obesity is a chronic disease warranting pharmaceutical intervention. Read More
The next Commissioner of the Food and Drug Administration does not need to be a physician. But he does need to be a diagnostician. The FDA's... Read More
As Washington considers who should next lead the Food and Drug Administration (FDA), there will be a familiar temptation to focus on... Read More
As regular HOTLINE readers will recall, the widely cited Unleash Prosperity Now study on the economic value of speeding up FDA drug approval,... Read More
The old paradigms are failing and new paradigms are struggling to be born. Standing in the breach are mainstream health science reporters. Read More
The best surgeons I trained with and worked alongside were not necessarily the most daring or dazzling; they understood that brilliance... Read More
Is euthanasia just bureaucratic cost cutting for Canada’s dysfunctional healthcare system? Read More
The UK Covid-19 Inquiry has released the political chapters of its long-awaited report. After nearly three years, the conclusion is clear. Read More
Organizations are encouraged to support employees in developing good lifestyle habits to increase work engagement. Read More
I’ve seen clients start GLP-1 medications full of hope—and stop them feeling betrayed by their own biology. Read More
If the FDA policed only safety, not efficacy, the result would be more innovation at lower cost. Read More
The Alzheimer’s Policy Working Group is a 501(c)(3) organization that unites frontline clinicians from specialty and primary care to... Read More
On Thursday, January 22, the House Energy and Commerce Committee and the House Ways and Means Committee will each hold a hearing with some of... Read More
This is the fourth part of a series on the crisis in academic research and publishing. Read the first three parts here, here and here. By... Read More
Introduction In August, AHIP, the trade association for health insurance companies representing the industry’s top players, announced... Read More
This is a difficult moment for Roe v. Wade to have fallen.... Read More
If Congress and the administration do not plan and work together, the end of the old emergency will only mark the beginning of a new emergency.... Read More
The Affordable Care Act has faded into the political background since Republicans failed to repeal the entitlement in 2017, but ObamaCare still doesn't work as promised. The Biden Administration said this week that it will throw more money at one problem, and the result will be to hook more Americans on government subsidies. ... Read More
